News for Healthier Living

AACR: Novel Approach Prevents Cancer Progression, Spares Surgery for Majority of Patients with Precancerous Oral Lesions

Direct injection of a low dose of the immune checkpoint inhibitor nivolumab into precancerous oral lesions significantly reduced lesion size and risk of cancer progression, sparing most patients from surgery. This new research from The University of Texas MD Anderson Cancer Center suggests a novel approach to oral cancer prevention through immune interception.

April 21, 2026


May 1 2026

April 30 2026

April 29 2026

April 28 2026

April 27 2026

April 26 2026

April 25 2026

April 24 2026

April 23 2026

April 22 2026

April 21 2026

April 20 2026

April 19 2026

April 18 2026